We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Nordson (NDSN) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect Nordson (NDSN - Free Report) to post quarterly earnings of $2.82 per share in its upcoming report, which indicates a year-over-year increase of 16.5%. Revenues are expected to be $731 million, up 7% from the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Nordson metrics that are commonly monitored and projected by Wall Street analysts.
It is projected by analysts that the 'Net Sales- Industrial Precision Solutions' will reach $337.18 million. The estimate points to a change of +5.8% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Advanced Technology Solutions' of $190.40 million. The estimate indicates a year-over-year change of +18.1%.
Based on the collective assessment of analysts, 'Net Sales- Medical and Fluid Solutions' should arrive at $213.44 million. The estimate points to a change of +5.2% from the year-ago quarter.
Over the past month, shares of Nordson have returned +1.3% versus the Zacks S&P 500 composite's +7.7% change. Currently, NDSN carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Countdown to Nordson (NDSN) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts expect Nordson (NDSN - Free Report) to post quarterly earnings of $2.82 per share in its upcoming report, which indicates a year-over-year increase of 16.5%. Revenues are expected to be $731 million, up 7% from the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Nordson metrics that are commonly monitored and projected by Wall Street analysts.
It is projected by analysts that the 'Net Sales- Industrial Precision Solutions' will reach $337.18 million. The estimate points to a change of +5.8% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Advanced Technology Solutions' of $190.40 million. The estimate indicates a year-over-year change of +18.1%.
Based on the collective assessment of analysts, 'Net Sales- Medical and Fluid Solutions' should arrive at $213.44 million. The estimate points to a change of +5.2% from the year-ago quarter.
View all Key Company Metrics for Nordson here>>>Over the past month, shares of Nordson have returned +1.3% versus the Zacks S&P 500 composite's +7.7% change. Currently, NDSN carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .